Please login to the form below

Not currently logged in
Email:
Password:

commentary

This page shows the latest commentary news and features for those working in and with pharma, biotech and healthcare.

Brexit to blame as firm plans to leave UK for Ireland

Brexit to blame as firm plans to leave UK for Ireland

Commentary. The news of Steris’ plans for redomiciling were picked up yesterday by the staunchly anti-Brexit Evening Standard (its editor-in-chief being ex-Chancellor of the Exchequer George Osborne).

Latest news

More from news
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Digital health Digital health

    For Craig Mills, founder of Frontera Group, commentary is still too focused on digital as a channel rather than as a game-changing enabler in health.

  • It’s time for pharma companies to become household names It’s time for pharma companies to become household names

    I'm talking about corporate visibility and authentic leadership, manifest through commentary and insights on issues that matter to the person on the street.

  • Pharma deals in May 2015 Pharma deals in May 2015

    In addition Lilly is making a $30m equity investment. Lilly has recently returned to the Deal Watch commentary and May saw the company build further on its long standing relationship with

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    Read the month's pharma deal commentary in full.]. Here Medius present a run down of the month's biggest mergers, acquisitions and collaborations from across the sector.

  • Pharma deals in April 2015 Pharma deals in April 2015

    The love affair with oncology continues, finds Medius Deal Watch

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics